UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035910
Receipt number R000040911
Scientific Title Intra-articular Platelet-rich plasma for Hip osteoarthritis
Date of disclosure of the study information 2019/02/18
Last modified on 2021/02/19 09:27:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intra-articular Platelet-rich plasma for Hip osteoarthritis

Acronym

IPHOK study

Scientific Title

Intra-articular Platelet-rich plasma for Hip osteoarthritis

Scientific Title:Acronym

IPHOK study

Region

Japan


Condition

Condition

osteoarthritis of hip

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effect of pain control of hip osteoarthritis by use of intra-articular injection of Platelet-rich plasma

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) -Pain

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intra-articular hyaluronic acid

Interventions/Control_2

Intra-articular platelet-rich plasma

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Female

Key inclusion criteria

Kellgren and Lawrence OA grade 1-3

Key exclusion criteria

post operative cases
rheumatoid Arthritis cases
osteonecrosis cases
Blood coagulation disorder cases
Infection cases
BMI is more than 30
No consent is obtained

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Masahiko
Middle name
Last name Ikeuchi

Organization

Kochi University Kochi Medical school

Division name

Department of ortopaedic surgery

Zip code

7838505

Address

Kohasu, Ocho-cho, Nankoku, Japan

TEL

0888802386

Email

ikeuchi@kochi-u.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Okanoue

Organization

Kochi University Kochi Medical school

Division name

Department of ortopaedic surgery

Zip code

783-8505

Address

Kohasu, Ocho-cho, Nankoku, Japan

TEL

0888802386

Homepage URL


Email

okanoue@kochi-u.ac.jp


Sponsor or person

Institute

Kochi University Kochi Medical school

Institute

Department

Personal name



Funding Source

Organization

Kochi University Kochi Medical school

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Correct health information for cooperative and innovatine development of society

Address

2-3-3 Koujimachi Chiyodaku, Tokyo ,Japan

Tel

03-5772-7584

Email

saisei@concide.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 11 Month 29 Day

Date of IRB

2018 Year 11 Month 29 Day

Anticipated trial start date

2019 Year 02 Month 18 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 18 Day

Last modified on

2021 Year 02 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040911


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name